Highlights Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

End-of-day quote Taipei Exchange Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
41.95 ^TWD	+0.24%		-0.83%	+7.84%

05/04	Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors	CI
29/03	Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Orient EuroPharma, OncoVent Sign License Deal	30/23/30	MT
OncoVent Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab	28/23/28	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/22/09	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Orient EuroPharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	11/21/11	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12/21/12	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	12/21/12	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
Regent Pacific Group Limited Announces Operation Update on Fortacin	18/21/18	CI
Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration	14/20/14	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	09/20/09	CI
Orient Europharma Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	10/20/10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

Highlights

Filters